273 related articles for article (PubMed ID: 31714653)
1. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
2. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
3. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376
[TBL] [Abstract][Full Text] [Related]
4. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
6. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
[TBL] [Abstract][Full Text] [Related]
7. Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma.
Li CH; Ku MC; Lee KC; Yueh PF; Hsu FT; Lin RF; Yang CC; Wang WC; Chen JH; Hsu LC; Lee YH
Anticancer Res; 2022 Sep; 42(9):4403-4410. PubMed ID: 36039427
[TBL] [Abstract][Full Text] [Related]
8. The
Chen YS; Sun R; Chen WL; Yau YC; Hsu FT; Chung JG; Tsai CJ; Hsieh CL; Chiu YM; Chen JH
In Vivo; 2020; 34(4):1789-1796. PubMed ID: 32606148
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model.
Hsu LC; Tu HF; Hsu FT; Yueh PF; Chiang IT
Biomed Pharmacother; 2020 Jun; 126():110054. PubMed ID: 32145588
[TBL] [Abstract][Full Text] [Related]
10. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
[TBL] [Abstract][Full Text] [Related]
11. Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation.
Lee KC; Chen WT; Liu YC; Lin SS; Hsu FT
In Vivo; 2018; 32(5):1097-1103. PubMed ID: 30150431
[TBL] [Abstract][Full Text] [Related]
12. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo.
Su CM; Lin SS; Wang HC; Hsu FT; Chung JG; Hsu LC
Environ Toxicol; 2022 Jan; 37(1):92-100. PubMed ID: 34626444
[TBL] [Abstract][Full Text] [Related]
14. Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis.
Hsu FT; Liu WL; Lee SR; Jeng LB; Chen JH
Phytomedicine; 2023 Oct; 119():154947. PubMed ID: 37549536
[TBL] [Abstract][Full Text] [Related]
15. Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells.
Lee YC; Weng YS; Wang HY; Hsu FT; Chueh FS; Wu JY; Chen WL; Chen JH
Anticancer Res; 2022 Aug; 42(8):3825-3833. PubMed ID: 35896265
[TBL] [Abstract][Full Text] [Related]
16. Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells.
Chunlian W; Heyong W; Jia X; Jie H; Xi C; Gentao L
Inflammation; 2014 Dec; 37(6):1957-67. PubMed ID: 24893579
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim HM; Bae SJ; Kim DW; Kim BK; Lee SB; Lee US; Kim CH; Moon SK
Int Immunopharmacol; 2007 Aug; 7(8):1083-91. PubMed ID: 17570325
[TBL] [Abstract][Full Text] [Related]
18. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
Tsai JJ; Pan PJ; Hsu FT
Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
[TBL] [Abstract][Full Text] [Related]
19. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.
Chiang IT; Liu YC; Wang WH; Hsu FT; Chen HW; Lin WJ; Chang WY; Hwang JJ
In Vivo; 2012; 26(4):671-81. PubMed ID: 22773582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
